Outcomes in patients with chronic kidney disease referred late to nephrologists: A meta-analysis

被引:142
作者
Chan, Micah R.
Dall, Aaron T.
Fletcher, Kathlyn E.
Lu, Na
Trivedi, Hariprasad
机构
[1] Med Coll Wisconsin, Dept Med, Div Gen Internal Med, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Div Gen Internal Med, Zablocki Vet Adm Med Ctr, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Grad Sch Biomed Sci, Hlth Policy Inst, Div Biostat, Milwaukee, WI 53226 USA
[4] Med Coll Wisconsin, Div Nephrol, Milwaukee, WI 53226 USA
[5] Affiliated Hosp, Milwaukee, WI USA
关键词
chronic kidney disease; dialysis; hospitalization; mortality; referral; timing;
D O I
10.1016/j.amjmed.2007.04.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: The study purpose was to compare differences in mortality and the duration of hospitalization in patients with chronic kidney disease who are referred early versus late to nephrologists. METHODS: We searched English-language literature from 1980 through December 2005, along with national conference proceedings, the Web of Science Citation Index, and reference lists of all included studies. Twenty-two studies with a total sample size of 12,749 met inclusion criteria. RESULTS: There was significantly increased overall mortality in the late referral group as compared with the early referral group ( relative risk 1.99; 95% confidence interval [CI], 1.66 to 2.39, P <.0001). The duration of hospital stay, at the time of initiation of renal replacement therapy, was greater in the late referred group by an average of 12 days ( 95% CI, 8.0 to 16.1, P=.0007). Significant heterogeneity was detected for both outcomes. CONCLUSION: Timing of referral emerged to be a significant factor impacting homogeneity in the mortality outcome. Our results suggest significantly higher mortality and increased early hospitalization of chronic kidney disease subjects referred late to nephrologists as compared with earlier referred subjects. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1063 / U19
页数:10
相关论文
共 46 条
[21]   The timing of specialist evaluation in chronic kidney disease and mortality [J].
Kinchen, KS ;
Sadler, J ;
Fink, N ;
Brookmeyer, R ;
Klag, MJ ;
Levey, AS ;
Powe, NR .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (06) :479-486
[22]   National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification [J].
Levey, AS ;
Coresh, J ;
Balk, E ;
Kausz, AT ;
Levin, A ;
Steffes, MW ;
Hogg, RJ ;
Perrone, RD ;
Lau, J ;
Eknoyan, G .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (02) :137-147
[23]  
Lhotta K, 2003, J NEPHROL, V16, P855
[24]   Improvement of clinical outcome by early nephrology referral in type II diabetics on hemodialysis [J].
Lin, CL ;
Wu, MS ;
Hsu, PY ;
Huang, CC .
RENAL FAILURE, 2003, 25 (03) :455-464
[25]   Renal function preservation in type 2 diabetes mellitus patients with early nephropathy:: A comparative prospective cohort study between primary health care doctors and a nephrologist [J].
Martínez-Ramírez, HR ;
Jalomo-Martínez, B ;
Cortés-Sanabria, L ;
Rojas-Campos, E ;
Barragán, G ;
Alfaro, G ;
Cueto-Manzano, AM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (01) :78-87
[26]  
Mendelssohn DC, 1999, CAN MED ASSOC J, V161, P413
[27]   LATE REFERRAL FOR MAINTENANCE DIALYSIS [J].
RATCLIFFE, PJ ;
PHILLIPS, RE ;
OLIVER, DO .
BRITISH MEDICAL JOURNAL, 1984, 288 (6415) :441-443
[28]  
Ravani P, 2003, J NEPHROL, V16, P862
[29]   HEALTH-RELATED QUALITY-OF-LIFE ASSOCIATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY FOR PREDIALYSIS CHRONIC RENAL-DISEASE PATIENTS [J].
REVICKI, DA ;
BROWN, RE ;
FEENY, DH ;
HENRY, D ;
TEEHAN, BP ;
RUDNICK, MR ;
BENZ, RL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (04) :548-554
[30]   Late referral for end-stage renal disease: a region-wide survey in the south west of England [J].
Roderick, P ;
Jones, C ;
Drey, N ;
Blakeley, S ;
Webster, P ;
Goddard, J ;
Garland, S ;
Bourton, L ;
Mason, J ;
Tomson, C .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (07) :1252-1259